OTC · REFG
Medical Cannabis Payment Solutions
$0.00$0.00 (0.0%)
Medical Cannabis Payment Solutions’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
OTC · PXYN · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Praxsyn Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Praxsyn Corporation operates as a healthcare enterprise, supplying medical professionals with specific medications and related services for their patients. The company specializes in creating non-narcotic and non-habit-forming treatments, utilizing therapeutic and preventative compounds. These come in various formats, such as transdermal creams, patches, and oral capsules, and are formulated to treat issues like pain management, erectile dysfunction, and metabolic disorders. Praxsyn's offerings are available to patients covered by California's workers' compensation program, along with those under preferred provider contracts. Established in 2005, the company was formerly known as The PAWS Pet Company, Inc. before changing its name to Praxsyn Corporation in March 2014. Its operations are based out of Las Vegas, Nevada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Medical Cannabis Payment Solutions’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Immunotech Laboratories, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Jack Nathan Medical Corp.’s quoted price sits in the lower half of its reported 52-week range, 94.15% below the high.
$0.00-$0.00 (-50.0%)
U.S. Stem Cell, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Manhattan Scientifics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Spencer Pharmaceutical Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
DNAPrint Genomics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
$0.00$0.00 (0.0%)
Lords & Company Worldwide Holdings Inc’s quoted price sits in the lower half of its reported 52-week range, 77.78% below the high.
